These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4945277)

  • 1. Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man.
    Sidell FR; Groff WA
    J Pharm Sci; 1971 Aug; 60(8):1224-8. PubMed ID: 4945277
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxogonin: oral administration to man.
    Sidell FR; Groff WA
    J Pharm Sci; 1971 Jun; 60(6):860-3. PubMed ID: 4942862
    [No Abstract]   [Full Text] [Related]  

  • 3. Human toxicity of various oximes. 2-Pyridine aldoxime methyl chloride, its methane sulfonate salt, and 1,1'-trimethylenebis-(4-formylpyridinium chloride).
    Calesnick B; Christensen ; Richter M
    Arch Environ Health; 1967 Nov; 15(5):599-608. PubMed ID: 6066265
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood concentrations of N,N'-trimethylenebis(pyridinium-4-aldoxime) (TMB-4) and N,N'-oxydimethlenebis (pyridinium-4-aldoxime) (toxogonin) after intravenous and intramuscular administration in the dog.
    Milosević M; Vojvodić V; Terzić M
    Biochem Pharmacol; 1967 Dec; 16(12):2435-8. PubMed ID: 6075402
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxogonin: blood levels and side effects after intramuscular administration in man.
    Sidell FR; Groff WA
    J Pharm Sci; 1970 Jun; 59(6):793-7. PubMed ID: 5423080
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of the effects of atropine on human heart rate by pralidoxime.
    Sidell FR; Magness JS; Bollen TE
    Clin Pharmacol Ther; 1970; 11(1):68-76. PubMed ID: 5410897
    [No Abstract]   [Full Text] [Related]  

  • 7. Pralidoxime mesylate absorption and heart rate response to atropine sulphate following intramuscular administration of solution mixtures.
    Holland P; Parkes DC; White RG
    Br J Clin Pharmacol; 1975 Aug; 2(4):333-8. PubMed ID: 788732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxogonin and pralidoxime: kinetic comparison after intravenous administration to man.
    Sidell FR; Groff WA; Kaminskis A
    J Pharm Sci; 1972 Nov; 61(11):1765-9. PubMed ID: 4569114
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposition kinetics of 2-pyridine aldoxime methochloride in Bubalus bubalis.
    Srivastava AK; Malik JK
    J Vet Pharmacol Ther; 1989 Mar; 12(1):103-8. PubMed ID: 2704055
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 2-pyridinium aldoxine methochloride and atropine in relation to elevation of blood pH in soman-poisoned dogs.
    Harris LW; Fleisher JH; Vick JA; Cliff WJ
    Biochem Pharmacol; 1969 Feb; 18(2):419-27. PubMed ID: 5778157
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of absorption and elimination of pralidoxime chloride in dogs.
    Lemanowicz EF; Sugita ET; Niebergall PJ; Schnaare RL
    J Pharm Sci; 1979 Feb; 68(2):141-5. PubMed ID: 423079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood levels of oxime and symptoms in humans after single and multiple oral doses of 2-pyridine aldoxime methochloride.
    Sidell FR; Groff WA; Ellin RI
    J Pharm Sci; 1969 Sep; 58(9):1093-8. PubMed ID: 5346072
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
    Simons KJ; Briggs CJ
    J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atropine sulphate absorption from an intramuscular injection of a mixture of the oxime, P2S, and atropine in exercising humans.
    Martin Hde V
    Br J Pharmacol; 1973 Mar; 47(3):619P. PubMed ID: 4354327
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Concentrations of the oxime 2-hydroxyiminomethyl pyridinium methyl methane sulphonate (P2S) after intramuscular injections in humans.
    Holland P; Parkes D; Shakespeare J
    Br J Pharmacol; 1972 Feb; 44(2):368P. PubMed ID: 4358414
    [No Abstract]   [Full Text] [Related]  

  • 16. Atropine sulphate absorption in humans after intramuscular injection of a mixture of the oxime-P2S and atropine.
    Holland P; White RG
    Br J Pharmacol; 1971 Aug; 42(4):645P-646P. PubMed ID: 5116047
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Lethal plasma concentrations of pralidoxime methane sulphonate (P2S) given parenterally.
    Ballantyne B; Gazzard MF; Robson OC; Swanston DW
    Br J Pharmacol; 1974 May; 51(1):119P-120P. PubMed ID: 4441769
    [No Abstract]   [Full Text] [Related]  

  • 18. Pralidoxime methanesulfonate: plasma levels and pharmacokinetics after oral administration to man.
    Sidell FR; Groff WA; Kaminskis A
    J Pharm Sci; 1972 Jul; 61(7):1136-40. PubMed ID: 5044817
    [No Abstract]   [Full Text] [Related]  

  • 19. A central vasodepressor effect of Dyflos.
    Edery H; Guertzenstein PG
    Br J Pharmacol; 1974 Apr; 50(4):481-7. PubMed ID: 4614881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac and peripheral vascular effects of pralidoxime chloride.
    Barnes GE; Bishop VS; Kardon MB
    Eur J Pharmacol; 1972 Nov; 20(2):188-94. PubMed ID: 4651207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.